ENTRY       D11124                      Drug
NAME        Suvratoxumab (USAN/INN)
FORMULA     C6556H10114N1730O2100S44
EXACT_MASS  148086.5522
MOL_WEIGHT  148177.6454
SEQUENCE    (Heavy chain)
            EVQLVESGGG LVQPGGSLRL SCAASGFTFS SHDMHWVRQA TGKGLEWVSG IGTAGDTYYP
            DSVKGRFTIS RENAKNSLYL QMNSLRAGDT AVYYCARDRY SPTGHYYGMD VWGQGTTVTV
            SSASTKGPSV FPLAPSSKST SGGTAALGCL VKDYFPEPVT VSWNSGALTS GVHTFPAVLQ
            SSGLYSLSSV VTVPSSSLGT QTYICNVNHK PSNTKVDKRV EPKSCDKTHT CPPCPAPELL
            GGPSVFLFPP KPKDTLYITR EPEVTCVVVD VSHEDPEVKF NWYVDGVEVH NAKTKPREEQ
            YNSTYRVVSV LTVLHQDWLN GKEYKCKVSN KALPAPIEKT ISKAKGQPRE PQVYTLPPSR
            EEMTKNQVSL TCLVKGFYPS DIAVEWESNG QPENNYKTTP PVLDSDGSFF LYSKLTVDKS
            RWQQGNVFSC SVMHEALHNH YTQKSLSLSP GK
            (Light chain)
            DIQMTQSPST LSASVGDRVT ITCRASQSIS SWLAWYQQKP GKAPKLLIYK ASSLESGVPS
            RFSGSGSGTE FTLTISSLQP DDFATYYCKQ YADYWTFGQG TKVEIKRTVA APSVFIFPPS
            DEQLKSGTAS VVCLLNNFYP REAKVQWKVD NALQSGNSQE SVTEQDSKDS TYSLSSTLTL
            SKADYEKHKV YACEVTHQGL SSPVTKSFNR GEC
  TYPE      Peptide
EFFICACY    Antibacterial
  TYPE      Monoclonal antibody
COMMENT     Prevention of nosocomial pneumonia caused by Staphylococcus aureus
DBLINKS     CAS: 1629620-18-3
            PubChem: 376219048
///
